Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Bulletin of the NYU Hospital for Joint Diseases
|
December 25, 2012
The year in gout: 2011-2012
Daria B Crittenden, Michael H Pillinger
Alimentary Pharmacology & Therapeutics
|
June 28, 2026
Letter: Assessing Pruritus Efficacy With Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis Must Include Grading the Strength of Trial Evidence
Daria B Crittenden, Gideon M Hirschfield
Bulletin of the NYU Hospital for Joint Diseases
|
November 1, 2011
The year in gout - 2010-2011
Daria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)
|
October 25, 2013
The year in gout: 2012-2013 - a walk through the 2012 ACR Gout Treatment Guidelines
Daria B Crittenden, Michael H Pillinger
Annual Review of Medicine
|
January 19, 2013
New therapies for gout
Daria B Crittenden, Michael H Pillinger
Archives of Internal Medicine
|
March 10, 2010
Metrics for evaluating the utility of patient-centered decision tools
Daria B Crittenden, Nirav R Shah
The New England Journal of Medicine
|
January 26, 2017
Romosozumab Treatment in Postmenopausal Osteoporosis
Felicia Cosman, Daria B Crittenden, Andreas Grauer
Southern Medical Journal
|
June 18, 2014
Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street
Elaine Karis, Daria B Crittenden, Michael H Pillinger
Current Rheumatology Reports
|
December 21, 2013
The crystallization of monosodium urate
Miguel A Martillo, Lama Nazzal, Daria B Crittenden
Archives of Osteoporosis
|
August 5, 2020
Predictors of imminent risk of fracture in Medicare-enrolled men and women
Akeem A Yusuf, Yan Hu, David Chandler, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Bulletin of the NYU Hospital for Joint Diseases
|
December 25, 2012
The year in gout: 2011-2012
Daria B Crittenden, Michael H Pillinger
Alimentary Pharmacology & Therapeutics
|
June 28, 2026
Letter: Assessing Pruritus Efficacy With Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis Must Include Grading the Strength of Trial Evidence
Daria B Crittenden, Gideon M Hirschfield
Bulletin of the NYU Hospital for Joint Diseases
|
November 1, 2011
The year in gout - 2010-2011
Daria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)
|
October 25, 2013
The year in gout: 2012-2013 - a walk through the 2012 ACR Gout Treatment Guidelines
Daria B Crittenden, Michael H Pillinger
Annual Review of Medicine
|
January 19, 2013
New therapies for gout
Daria B Crittenden, Michael H Pillinger
Archives of Internal Medicine
|
March 10, 2010
Metrics for evaluating the utility of patient-centered decision tools
Daria B Crittenden, Nirav R Shah
The New England Journal of Medicine
|
January 26, 2017
Romosozumab Treatment in Postmenopausal Osteoporosis
Felicia Cosman, Daria B Crittenden, Andreas Grauer
Southern Medical Journal
|
June 18, 2014
Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street
Elaine Karis, Daria B Crittenden, Michael H Pillinger
Current Rheumatology Reports
|
December 21, 2013
The crystallization of monosodium urate
Miguel A Martillo, Lama Nazzal, Daria B Crittenden
Archives of Osteoporosis
|
August 5, 2020
Predictors of imminent risk of fracture in Medicare-enrolled men and women
Akeem A Yusuf, Yan Hu, David Chandler, et al.
Page
of 4